Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease
- PMID: 9046040
Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease
Abstract
Parkinson's disease (PD) is a neurodegenerative disorder characterized by progressive cell loss confined mostly to dopaminergic neurons of the substantia nigra. Several factors, including oxidative stress, and decreased activity of complex I mitochondrial respiratory chain, are involved in the degenerative process. Yet, the underlying mechanisms leading to dopaminergic cell loss remain elusive. Morphological assessment for different modes of cell death: apoptosis, necrosis or autophagic degeneration, can contribute significantly to the understanding of this neuronal loss. Ultrastructural examination revealed characteristics of apoptosis and autophagic degeneration in melanized neurons of the substantia nigra in PD patients. The results suggest that even at the final stage of the disease, the dopaminergic neurons are undergoing active process of cell death.
Similar articles
-
Apoptosis in dopaminergic neurons of the human substantia nigra during normal aging.Histol Histopathol. 1997 Jul;12(3):603-10. Histol Histopathol. 1997. PMID: 9225140
-
Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.Neuroscience. 2006 Jun 19;140(1):67-76. doi: 10.1016/j.neuroscience.2006.02.007. Epub 2006 Mar 14. Neuroscience. 2006. PMID: 16533572
-
Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.Brain. 2005 Nov;128(Pt 11):2654-64. doi: 10.1093/brain/awh584. Epub 2005 Jul 6. Brain. 2005. PMID: 16000336
-
Pathogenesis of nigral cell death in Parkinson's disease.Parkinsonism Relat Disord. 2005 Jun;11 Suppl 1:S3-7. doi: 10.1016/j.parkreldis.2004.10.012. Parkinsonism Relat Disord. 2005. PMID: 15885625 Review.
-
The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease.Exp Neurol. 1993 Nov;124(1):103-18. doi: 10.1006/exnr.1993.1181. Exp Neurol. 1993. PMID: 8282068 Review.
Cited by
-
Optic atrophy 1 mediates mitochondria remodeling and dopaminergic neurodegeneration linked to complex I deficiency.Cell Death Differ. 2013 Jan;20(1):77-85. doi: 10.1038/cdd.2012.95. Epub 2012 Aug 3. Cell Death Differ. 2013. PMID: 22858546 Free PMC article.
-
Effect of citronellol on oxidative stress, neuroinflammation and autophagy pathways in an in vivo model of Parkinson's disease.Heliyon. 2022 Nov 3;8(11):e11434. doi: 10.1016/j.heliyon.2022.e11434. eCollection 2022 Nov. Heliyon. 2022. PMID: 36387498 Free PMC article.
-
Mass Spectrometry Analysis of Neurotransmitter Shifting during Neurogenesis and Neurodegeneration of PC12 Cells.Int J Mol Sci. 2024 Sep 27;25(19):10399. doi: 10.3390/ijms251910399. Int J Mol Sci. 2024. PMID: 39408728 Free PMC article.
-
Biology of endophilin and it's role in disease.Front Immunol. 2023 Dec 5;14:1297506. doi: 10.3389/fimmu.2023.1297506. eCollection 2023. Front Immunol. 2023. PMID: 38116012 Free PMC article. Review.
-
TRPC1 protects human SH-SY5Y cells against salsolinol-induced cytotoxicity by inhibiting apoptosis.Brain Res. 2006 Jul 12;1099(1):141-9. doi: 10.1016/j.brainres.2006.04.104. Epub 2006 Jun 12. Brain Res. 2006. PMID: 16765919 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical